Slideshow

Antipsychotics-To Respond or Not to Respond?

Author(s):

Brian Miller, MD, PhD, MPH

A new study brings us closer to answering why antipsychotics are successful in treating schizophrenia in some patients and not in others.

Related Videos
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
nicotine use
brain schizophrenia
schizophrenia
schizophrenia
exciting, brain
Related Content
Psychiatric Times Through the Years: the Last 5 Years in January Covers
January 31st 2025

Psychiatric Times Through the Years: the Last 5 Years in January Covers

Megan McSweeney
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
schizophrenia
January 18th 2025

Recovery as the Goal: Challenges in Schizophrenia Treatment

Michael Asbach, DMSc, PA-C, Psych-CAQ
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD
digital brain
January 17th 2025

Breaking Down Barriers to Quality Care for Patients With Schizophrenia

Leah Kuntz
Disappointing Data From Phase III CONNEX for Iclepertin in Addressing Cognition Impairment in Schizophrenia
January 16th 2025

Disappointing Data From Phase III CONNEX for Iclepertin in Addressing Cognition Impairment in Schizophrenia

Heidi Anne Duerr, MPH
© 2025 MJH Life Sciences

All rights reserved.